Literature DB >> 23362386

Prolene monofilament suture in Boston Keratoprosthesis surgery.

Ralph Kyrillos1, Mona Harissi-Dagher.   

Abstract

Toxic reaction to nylon following uncomplicated cataract surgery and vitrectomy has been documented in the literature. We report the case of an aniridic patient with a known adverse reaction to nylon in whom Prolene suture was used in Boston Keratoprosthesis type 1 (KPro) surgery. During follow-up the cornea was checked for signs of inflammation and toxic reaction; at last follow-up (18 months) the patient showed no signs of complications due to Prolene. Our study suggests that Prolene suture may be used as an alternative to nylon in Boston KPro surgery in patients with a history of nylon toxicity.

Entities:  

Year:  2011        PMID: 23362386      PMCID: PMC3516155          DOI: 10.5693/djo.02.2011.02.001

Source DB:  PubMed          Journal:  Digit J Ophthalmol        ISSN: 1542-8958


  7 in total

1.  Nylon suture toxicity after cataract surgery.

Authors:  H D Balyeat; R M Davis; J J Rowsey
Journal:  Ophthalmology       Date:  1988-11       Impact factor: 12.079

2.  Comparison of tissue reaction to nylon and prolene sutures in rabbit iris and cornea.

Authors:  S E Kelly; J Ehlers; I Llovera; R C Troutman
Journal:  Ophthalmic Surg       Date:  1975

3.  [Complications caused by prolene].

Authors:  P Turut; P Florin; J Courtin
Journal:  Bull Soc Ophtalmol Fr       Date:  1981 Aug-Sep

4.  The pathogenesis of suture toxicity.

Authors:  S B Aronson; P R McMaster; T E Moore; M A Coon
Journal:  Arch Ophthalmol       Date:  1970-11

5.  Nylon suture toxicity after vitrectomy surgery.

Authors:  R J Schechter
Journal:  Ann Ophthalmol       Date:  1990-09

6.  [Short and long-term advantages and disadvantages of prolene monofilament sutures in penetrating keratoplasty].

Authors:  R Faggioni; C de Courten
Journal:  Klin Monbl Augenheilkd       Date:  1992-05       Impact factor: 0.700

7.  [Supposed nylon allergy after cataract surgery].

Authors:  I Elosúa de Juan; S López García; M Bové Guri; E Mata Díaz; J Martínez Garchitorena
Journal:  Arch Soc Esp Oftalmol       Date:  2001-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.